Infinity Bio To Host Open House at State-of-the-Art Laboratory
July 10 2024 - 8:00AM
Business Wire
Company offers cutting-edge solutions and services to pharma,
academia, and the greater biomedical research community.
Infinity Bio, a technology company known for its innovative
antibody reactome profiling service, will host an open house event
at its state-of-the-art laboratory at 6200 Seaforth Street in
Baltimore on July 23, 2024. This event is designed to give members
of the local scientific and biotech community an exclusive look at
the research and technologies that are driving developments in
immunology.
Infinity Bio, founded in 2023, utilizes its proprietary MIPSA
technology to perform advanced antibody reactivity profiling,
providing deep insights that are crucial for developing
next-generation therapeutics and diagnostics. The company’s core
technology comprehensively measures the antibody reactome,
revealing the targets of individual immune responses against all
known human viruses, human proteins (autoimmunity), and allergen
proteins. Developed at Johns Hopkins University in Dr. H. Benjamin
Larman's Laboratory of Precision Immunology, Infinity Bio’s assay
builds off decades of work in genomics, proteomics, immunology, and
bioinformatics, ensuring best-in-class turnaround times and cost
efficiency. Larman also serves as Infinity Bio’s Chief Science
Officer.
The event will include live demonstrations of sample processing
through their state-of-the-art automation system, Q&A sessions
with Infinity Bio’s researchers, and a preview of informatics
reporting. Attendees will also have the chance to network with
other professionals in the field.
“We are eager to showcase our laboratory, commitment to quality,
and our team,” says Joy M. Nassif, CEO of Infinity Bio. “Our team
is dedicated to the pursuit of scientific excellence and customer
delight, and we believe that transparency and collaboration are key
to driving innovation.”
Larman states: “The open house will be a unique opportunity for
researchers in academia and biotech to learn about our industry
leading antibody reactome profiling services, and to see for
themselves how Infinity Bio can transform their immunology
research.”
To register for the open house, please visit
https://www.infinitybio.com/open-house-rsvp.
ABOUT INFINITY BIO Infinity Bio, Inc. is a technology
company that provides detailed insights into the immune system
using its proprietary antibody profiling platform. The company’s
core technology comprehensively measures the antibody reactome,
revealing the targets of individual immune responses against all
known human viruses, human proteins (autoimmunity), and allergen
proteins. Infinity's assay, MIPSA, was developed at Johns Hopkins
University in Dr. H. Benjamin Larman's Laboratory of Precision
Immunology. It builds off of decades of work in the fields of
genomics, proteomics, immunology, and bioinformatics. Our assay was
engineered to enable best-in-class turnaround times and core to our
values are quality and customer delight.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240710590698/en/
Media: Josie Zohny Clarity Quest Phone: 877-887-7611
Email: josie@clarityqst.com